Gilead Sciences reported $21.47B in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acorda Therapeutics ACOR:US $ 164.48M 26.01M
Agios Pharmaceuticals AGIO:US $ 1394.76M 327.05M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
ALKERMES ALKS:US $ 1096.17M 1.73M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Amgen AMGN:US $ 8217M 30M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
Biogen BIIB:US $ 10429.9M 322M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Bristol Myers Squibb BMY:US $ 37213M 405M
Coherus Biosciences CHRS:US $ 130.76M 25.46M
Eli Lilly And LLY:US $ 7757M 1312.6M
Gilead Sciences GILD:US $ 21471M 1768M
Glaxosmithkline GSK:US $ 15426M 49M
GlaxoSmithKline GSK:LN 15426M 49M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Moderna Inc MRNA:US 10.12B 3.42B
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Novartis NOVN:VX SF 56771M 2729M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Puma Biotechnology PBYI:US $ -10.92M 40.39M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Teva Pharmaceutical Industries TEVA:US $ 10467M 143M
United Therapeutics UTHR:US $ 3829.7M 190.2M
Vertex Pharmaceuticals VRTX:US $ 9530.71M 334.31M
YTE INCY:US $ 3148.66M 212.8M